Johny Marice
For decades, the intricate mechanisms governing appetite have been largely attributed to the complex interplay of neurons, the brain’s primary electrical communicators. However, a groundbreaking study published in the Proceedings of the National Academy of Sciences on April 6, 2026, is poised to rewrite our understanding, revealing a far more nuanced system where glial cells, particularly astrocytes, play a pivotal and active role in regulating hunger and satiety. This research, a culmination of nearly a decade of dedicated scientific collaboration between the University of Concepción in Chile and the University of Maryland in the United States, uncovers a novel signaling pathway within the hypothalamus, the brain’s central command for energy balance, offering significant potential for future therapeutic interventions in conditions like obesity and eating disorders.
Rethinking Brain Communication: The Ascendancy of Astrocytes
The prevailing paradigm in neuroscience has long centered on neurons as the sole architects of brain function. Their capacity for rapid electrical signaling and synaptic transmission has made them the focal point of research into everything from memory formation to motor control, and critically, appetite regulation. Yet, a parallel universe of non-neuronal cells, the glia, which constitute a significant proportion of the brain’s cellular mass, have historically been relegated to supporting roles. Astrocytes, star-shaped glial cells, were predominantly viewed as passive caretakers, providing structural support, nutrient supply, and waste removal for their neuronal counterparts.
This long-held view is now being challenged by the findings of researchers at the University of Concepción and the University of Maryland. Their comprehensive study illuminates a sophisticated communication network where astrocytes are not merely bystanders but active participants, directly influencing the brain’s perception of hunger and fullness. This paradigm shift underscores the evolving nature of neuroscience, moving beyond a neuron-centric model to embrace a more integrated understanding of brain circuitry.
The Hypothalamus: A Central Hub for Energy Balance
The hypothalamus, a small but vital region located at the base of the brain, serves as the primary control center for maintaining energy homeostasis. It integrates signals from the body related to nutrient availability, hormonal cues, and neural inputs to orchestrate the complex behaviors of eating and fasting. Within the hypothalamus, specific nuclei, such as the arcuate nucleus, house populations of neurons that either stimulate appetite (orexigenic neurons) or suppress it (anorexigenic neurons).
Understanding how these neuronal populations are precisely regulated has been a key objective in the fight against metabolic diseases. Previous research had identified the role of glucose detection in this process. Specialized cells known as tanycytes, which line the walls of the third ventricle, a fluid-filled cavity within the brain, were known to monitor glucose levels in the cerebrospinal fluid. It was understood that upon detecting an increase in glucose following a meal, these tanycytes would initiate a signal that eventually reached the appetite-regulating neurons. However, the precise nature of this signal and the intermediaries involved remained elusive until now.
Unraveling the Tanycyte-Astrocyte-Neuron Axis
The pivotal discovery of this research lies in identifying astrocytes as a crucial intermediary in the signaling cascade initiated by tanycytes. The study, spearheaded by doctoral student Sergio López under the joint mentorship of Professor Ricardo Araneda from the University of Maryland and Professor María de los Ángeles García-Robles from the University of Concepción, meticulously details a previously unrecognized pathway.
The process begins with tanycytes, specialized ependymal cells that form a layer around the circumventricular organs, including the floor of the third ventricle. These cells are strategically positioned to sense changes in the composition of the cerebrospinal fluid, which directly reflects the body’s metabolic state. Following a meal, as blood glucose levels rise, so too does the glucose concentration in the cerebrospinal fluid. Tanycytes, equipped to detect this surge, metabolize the glucose. A key output of this metabolic process is the release of lactate, a molecule traditionally associated with anaerobic respiration but increasingly recognized for its signaling roles in the brain.
Crucially, the research demonstrates that this tanycyte-derived lactate does not directly communicate with the appetite-controlling neurons. Instead, it acts as a messenger to nearby astrocytes. "Researchers used to think that lactate produced from tanycytes ‘spoke’ directly to neurons involved in appetite control," explained Professor Ricardo Araneda, a corresponding author of the study. "But we found that there was an unexpected middleman in that conversation, astrocytes."
Astrocytes: More Than Just Support
Astrocytes, which are the most abundant type of glial cell in the brain, have long been characterized by their diverse functions, including buffering ions, providing metabolic support to neurons, and contributing to synaptic plasticity. However, this study elevates their role to that of active signal integrators and transmitters within the appetite regulation circuitry.
The researchers identified a specific receptor on the surface of astrocytes, known as HCAR1 (Hydroxycarboxylic acid receptor 1). This receptor is highly sensitive to lactate. When lactate molecules released by tanycytes bind to HCAR1 on astrocytes, it triggers a cascade of intracellular events within the astrocyte. This activation leads to the release of glutamate, a major excitatory neurotransmitter in the brain.
Glutamate, in turn, acts on specific neurons in the hypothalamus that are known to suppress appetite. This mechanism effectively translates the detection of increased glucose into a signal that promotes feelings of fullness, thereby contributing to the cessation of eating. Professor Araneda elaborated on the complexity of this interaction: "What surprised us was the complexity of it. To put it simply, we found that tanycytes ‘talk’ to astrocytes, and then astrocytes ‘talk’ to neurons."
A Sophisticated Signaling Network
The research further elucidates the intricate nature of this communication. In controlled experiments, scientists observed that even a localized introduction of glucose to a single tanycyte could elicit a widespread activation of surrounding astrocytes. This observation highlights the capacity of this signaling pathway to amplify and propagate information across the neuronal network, underscoring the efficiency of this newly discovered circuit.
Furthermore, the study suggests a potential dual role for tanycyte-derived lactate, mediated by astrocytes. The hypothalamus contains two opposing neuronal populations: those that promote hunger and those that suppress it. The findings indicate that lactate, through its action on astrocytes, could simultaneously activate the neurons that signal fullness while potentially inhibiting the neurons that stimulate hunger. This suggests a finely tuned system capable of both promoting satiety and modulating the drive to eat.
Implications for Metabolic Health: A New Frontier in Treatment
The implications of this discovery are far-reaching, particularly for the millions of individuals worldwide struggling with obesity and eating disorders. While the current research was conducted in animal models, the fundamental cellular components—tanycytes and astrocytes—are conserved across all mammalian species, including humans. This suggests that the identified signaling pathway is likely to be operative in humans as well.
The research team plans to conduct further investigations to determine if manipulating the HCAR1 receptor in astrocytes can directly influence eating behavior. This crucial step will pave the way for the development of novel therapeutic strategies. Currently, no pharmaceutical interventions directly target this specific tanycyte-astrocyte-neuron axis. However, Professor Araneda expressed optimism about its therapeutic potential.
"We now have a different mechanism where we might be able to target astrocytes or specifically this HCAR1 receptor," he stated. "It would be a novel target that may complement existing therapies like Ozempic, for example, and improve the lives of many who suffer from obesity and other appetite-related conditions." The prospect of developing drugs that specifically modulate this pathway could offer a more targeted and potentially effective approach to managing appetite dysregulation, complementing existing treatments that often have broader systemic effects.
A Decade of Collaborative Research
This significant scientific achievement is the culmination of a dedicated, decade-long collaboration between Professor Araneda’s laboratory at the University of Maryland and Professor García-Robles’ laboratory at the University of Concepción. The project’s lead author, Sergio López, a doctoral student co-mentored by both researchers, played a pivotal role, conducting key experiments during an eight-month research visit to the University of Maryland. This international partnership underscores the power of global scientific cooperation in advancing fundamental knowledge.
The study, titled "Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability," was meticulously peer-reviewed and published in the esteemed Proceedings of the National Academy of Sciences. Funding for this groundbreaking research was provided by Chile’s National Fund for Scientific and Technological Development, the Millennium Institute of Neuroscience in Valparaíso, and the U.S. National Institutes of Health (Award No. R01AG088147A). While these organizations supported the research, the views expressed in the article are those of the researchers and do not necessarily reflect the official positions of the funding bodies. This discovery not only expands our understanding of brain function but also opens promising avenues for addressing significant public health challenges.
